Loading…
← Back to schedule
Executive Interview: Exploring Accelerated Drug Development through AI
Wednesday May 14, 2025 1:45pm - 2:05pm EDT
Small molecules are the cornerstone of drug discovery. With the evolution of innovation in drug development, there is an increase in the possibilities in addressing complex diseases including autoimmune disorders, cancer, and cardiovascular conditions.

This executive interview, with BPGbio President and CEO Niven Narain, will dive into how technological advances have pushed for new methods of drug development. We will take a look at the intersection between biology and AI to discover not only how technology and innovation are advancing and creating new opportunities but also spurring on the discovery of how patients react to potential drugs, creating  commercial viability and much more. Don't miss this exciting interview with one of biotech's leading voices in the AI and biologics space.
Speakers
avatar for Chris Hayden

Chris Hayden

Conference Producer, Fierce Life Sciences
avatar for Dr. Niven R. Narain

Dr. Niven R. Narain

President and CEO, BPGbio
Dr. Niven R. Narain is President and CEO of BPGbio, an AI-powered, biology-first biopharma company with a deep pipeline in oncology, CNS, and rare disease. A recognized leader in precision medicine and AI, he led the development of the NAi Interrogative Biology® platform and holds... Read More →
Wednesday May 14, 2025 1:45pm - 2:05pm EDT

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link